Based on the efficacy data in PDAC cell lines and Colo-357 tumour spheroids, we can assume that newly developed KV1.3 inhibitors do not reach the mitochondrial KV1.3 channels required for the induction of apoptosis. The gene discussed is KCNA3; the disease is neoplasm.